VIM and rheumatoid arthritis: The discovery of other antigenic targets like citrullinated fibrinogen[17], alpha-enolase[18], or vimentin[19] added valuable information about the serological status and progression of RA and proved the existence of distinct antibody subtypes (which can readily be explained by the RA disease course[20,21]).